Pharma growth: AstraZeneca profit surges 77% to $2.53 bn in Q3; US expansion and cancer drugs power strong results
AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and robust sales of its cancer drugs. ...
Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments
Novo Nordisk is set to reduce its workforce by 11%, eliminating 9,000 jobs globally, including 5,000 in Denmark, to save $1.3 billion amid rising competition ...
